Incyte Corp (NASDAQ: INCY) is 8.51% higher on its value in year-to-date trading and has touched a low of $50.35 and a high of $83.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INCY stock was last observed hovering at around $75.26 in the last trading session, with the day’s loss setting it -0.31%.
Currently trading at $74.95, the stock is 2.58% and 4.05% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.34 million and changing -0.41% at the moment leaves the stock 14.09% off its SMA200. INCY registered 29.09% gain for a year compared to 6-month gain of 22.33%. The firm has a 50-day simple moving average (SMA 50) of $71.9398 and a 200-day simple moving average (SMA200) of $65.5794.
The stock witnessed a 4.23% loss in the last 1 month and extending the period to 3 months gives it a -1.06%, and is 1.60% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.48% over the week and 2.57% over the month.
Incyte Corp (INCY) has around 2524 employees, a market worth around $14.44B and $4.08B in sales. Current P/E ratio is 530.81 and Fwd P/E is 12.69. Profit margin for the company is 0.80%. Distance from 52-week low is 48.86% and -10.72% from its 52-week high. The company has generated returns on investments over the last 12 months (1.02%).
with sales reaching $1.14B over the same period.The EPS is expected to shrink by -63.73% this year, but quarterly earnings will post 13.58% year-over-year. Quarterly sales are estimated to grow 12.87% in year-over-year returns.
944.0 institutions hold shares in Incyte Corp (INCY), with institutional investors hold 99.63% of the company’s shares. The shares outstanding are 192.80M, and float is at 189.54M with Short Float at 2.66%. Institutions hold 97.59% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 30.74 million shares valued at $1.86 billion. The investor’s holdings represent 13.693 of the INCY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 21.36 million shares valued at $1.29 billion to account for 9.5135 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 20.38 million shares representing 9.0766 and valued at over $1.24 billion, while DODGE & COX holds 6.8064 of the shares totaling 15.28 million with a market value of $926.23 million.
Incyte Corp (INCY) Insider Activity
The most recent transaction is an insider sale by Stein Steven H, the company’s EVP & Chief Medical Officer. SEC filings show that Stein Steven H sold 12,352 shares of the company’s common stock on Jan 21 ’25 at a price of $72.69 per share for a total of $0.9 million. Following the sale, the insider now owns 66967.0 shares.
Still, SEC filings show that on Dec 13 ’24, Tray Thomas (Principal Accounting Officer) disposed off 650 shares at an average price of $70.64 for $45916.0. The insider now directly holds 23,962 shares of Incyte Corp (INCY).
